MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
ENGN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

enGene Therapeutics (ENGN) Ownership - Who owns enGene Therapeutics?

enGene Therapeutics Inc is a clinical-stage biotechnology company mainstreaming gene therapy through the delivery of therapeutics to mucosal tissues and other organs, to create new ways to address diseases with high clinical needs... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
N/A
Address
4868 Rue Levy
Phone
+1 514 332-4888
Employees
82
Web
https://www.engene.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
113.55M
P/E Ratio
N/A
Total Cash
275.95M
Projected Growth
N/A
Total Debt
33.46M
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
4.12
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
ENGN
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
View AI-Driven Trading for ENGN
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Details
Industry
N/A
Address
4868 Rue Levy
Phone
+1 514 332-4888
Employees
82
Web
https://www.engene.com